Press & Media

Updated June 2, 2025

For all press or media inquiries, please contact:

3.25.25

BioLab Holdings, Inc. Announces Medical Advisory Board

Distinguished Wound Care Specialists to Provide Invaluable Insights Across BioLab's Operations

3.07.25

BioLab Holdings, Inc. Announces Partnership with Real Collagen GmbH

Investment and Partnership will Allow Manufacturer to Create New Wound Care Products UsingFish Collagen

2.12.25

BioLab Holdings, Inc. Receives IRB Approval for Trial on Membrane Wrap™

Study will Evaluate Efficacy of Skin Substitute on Venous Leg Ulcers

01.06.25

BioLab Holdings, Inc. Completes Animal Study on New Wound Care Product

Product Shows Promising Long-Term Results in New Study

10.31.24

BioLab Holdings, Inc. Launches Charity Care Program to Serve Uninsured

Wound Care Manufacturer to Donate Advanced Skin Substitutes to Qualifying Patients in Need

10.02.24

BioLab Holdings, Inc. Launches New Triple Layer Amniotic Skin Substitute Product

Tri-Membrane Wrap Developed to Protect Deep Wounds in Difficult-to-Cover Areas

BLS SALES & MARKETING
BLS LABS